SCHEMBL24908328

SCHEMBL24908328

Bc1c(B)c(B)c2c(-c3cccc4oc5c6ccccc6ccc5c34)c3c(B)c(B)c(B)c(B)c3c(-c3ccc(-c4ccc5c(ccc6ccccc65)c4)cc3)c2c1B

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 12/20 0.37
CYP1B1 Q16678 12/20 0.37
CYP1A2 P05177 11/20 0.33
PRKDC P78527 3/20 0.33
CYP3A4 P08684 2/20 0.33
TSHR P16473 2/20 0.33
CYP2C19 P33261 2/20 0.33
PSMD14 O00487 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PDE5A O76074 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
ABCB1 P08183 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP19A1 P11511 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24479487 0.91 L3MBTL1 (0.37) CYP1A2CYP3A4TSHRCYP2C19TDP1
SCHEMBL22382184 0.90 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2PRKDCCYP3A4
SCHEMBL21940072 0.90 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2PRKDCCYP3A4
SCHEMBL24766722 0.87 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2PRKDCCYP3A4
SCHEMBL26591896 0.86 ARSA (0.38) CYP1A1CYP1B1CYP1A2PRKDCCYP3A4
SCHEMBL24822733 0.85 L3MBTL1 (0.36) CYP1A1CYP1A2CYP3A4TSHRCYP2C19
SCHEMBL24481438 0.85 ARSA (0.34) CYP1A1CYP1B1CYP1A2PRKDCCYP3A4
SCHEMBL24735358 0.85 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2PRKDCCYP3A4
SCHEMBL26591498 0.85 ARSA (0.37) CYP1A1CYP1B1CYP1A2PRKDCCYP3A4
SCHEMBL24479815 0.84 ESR1 (0.35) CYP1A2CYP3A4TSHRCYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS MRPS22, RER1, EMC2 CYP1A1 2906/4885CYP1B1 3906/4885CYP1A2 2560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.